Similar articles

• The integration of chemotherapy, radiotherapy and transurethral surgery in bladder-sparing approaches for patients with invasive tumors.

  Shipley WU, Kaufman DS, Heney NM, Griffin PP, Althausen AF, Prout GR Jr. Shipley WU, et al. Prog Clin Biol Res. 1990;353:85-94. Prog Clin Biol Res. 1990. PMID: 2217430 Review. No abstract available.
• The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.

  deVere White RW, Katz MH, Steinberg GD. deVere White RW, et al. J Urol. 2009 May;181(5):1994-7. doi: 10.1016/j.juro.2009.02.052. Epub 2009 Mar 14. J Urol. 2009. PMID: 19286209 Review. No abstract available.
• Chemotherapy for invasive bladder cancer: facts and fallacies.

  Raghavan D, Pearson BS, Coorey GJ, Boulas J, Rosen IM, Mameghan H, Learoyd HM, Duval P. Raghavan D, et al. Arch Esp Urol. 1990;43 Suppl 2:209-14. Arch Esp Urol. 1990. PMID: 2096781 Review. No abstract available.
• Radical TUR and chemotherapy aiming at bladder preservation.

  Hall RR, Roberts JT, Marsh MM. Hall RR, et al. Prog Clin Biol Res. 1990;353:163-8. Prog Clin Biol Res. 1990. PMID: 2217414 No abstract available.
• Adjuvant chemotherapy of bladder cancer.

  Freiha FS, Torti FM. Freiha FS, et al. Prog Clin Biol Res. 1988;260:545-9. Prog Clin Biol Res. 1988. PMID: 3129738 Clinical Trial. No abstract available.